Orchestra BioMed Holdings, Inc. - Ordinary Shares

Share · US68572M1062 · OBIO (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Orchestra BioMed Holdings, Inc. - Ordinary Shares

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

28.04.2026 20:00

Current Prices from Orchestra BioMed Holdings, Inc. - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	OBIO	USD	28.04.2026 20:00	3,90 USD	-0,20 USD -4,88 %
IEX	OBIO	USD	28.04.2026 19:59	3,89 USD	-0,21 USD -5,12 %

Share Float & Liquidity

Free Float 74,77 %

Shares Float 43,76 M

Shares Outstanding 58,52 M

Company Profile for Orchestra BioMed Holdings, Inc. - Ordinary Shares Share

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.